Appili Therapeutics (Appili Therapeutics) Other Current Liabilities : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Appili Therapeutics Other Current Liabilities?

Appili Therapeutics's other current liabilities for the quarter that ended in Dec. 2023 was $0.00 Mil.

Appili Therapeutics's quarterly other current liabilities increased from Jun. 2023 ($0.00 Mil) to Sep. 2023 ($0.00 Mil) but then declined from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.00 Mil).

Appili Therapeutics's annual other current liabilities increased from Mar. 2021 ($0.00 Mil) to Mar. 2022 ($0.09 Mil) but then declined from Mar. 2022 ($0.09 Mil) to Mar. 2023 ($0.00 Mil).

Appili Therapeutics Other Current Liabilities Historical Data

The historical data trend for Appili Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Appili Therapeutics Other Current Liabilities Chart

Appili Therapeutics Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Current Liabilities

Get a 7-Day Free Trial

Appili Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Appili Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Appili Therapeutics Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Appili Therapeutics's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Appili Therapeutics (Appili Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Appili Therapeutics Inc (OTCPK:APLIF) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

APLI:Canada

Address

1344 Summer Street, Suite 21, Halifax, NS, CAN, B3H 0A8

Website

https://www.appilitherapeutics.com

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.